Molecular profiling could reduce both overtreatment and undertreatment of patients with high-intermediate risk endometrial ...

The IAEA has developed a brachytherapy dosimetry methodology which serves as the basis for a new audit service provided by the Agency’s Dosimetry Laboratory. For millions of cancer patients around the ...

“Brachytherapy is an important tool in our toolbox, but it is one of many options we provide within our multidisciplinary program.” For example, radiation oncology, neuro-oncology, and thoracic ...

Recurrent endometrial cancer is cancer that returns after treatment, often in the pelvis, lymph nodes, or distant organs, requiring further therapy.

Vaginal cuff brachytherapy (VCB) is widely used for adjuvant treatment of endometrial cancer, yet limited randomized data examine the optimal dose/fractionation. We aimed to study short-course VCB ...

Short-course vaginal cuff brachytherapy (VCB) is noninferior to standard regimens for short-term quality of life in people with early-stage endometrial cancer.

THURSDAY, Feb. 20, 2025 (HealthDay News) — Short-course vaginal cuff brachytherapy (VCB) is noninferior to standard regimens for short-term quality of life in people with early-stage endometrial ...

Short-course vaginal cuff brachytherapy is noninferior to standard regimens for short-term quality of life in people with early-stage endometrial cancer.

In a randomized clinical trial, researchers from Huntsman Cancer Institute at the University of Utah (the U) have found that short-course, higher-dose vaginal brachytherapy for endometrial cancer ...

In a randomized clinical trial, researchers from Huntsman Cancer Institute at the University of Utah (the U) have found that short-course, higher dose vaginal brachytherapy for endometrial cancer ...

Researchers at Huntsman Cancer Institute have found that fewer sessions of higher dose vaginal cuff brachytherapy work just as well as more frequent, lower-dose treatments for endometrial cancer ...

Vaginal cuff brachytherapy (VCB) is widely used for adjuvant treatment of endometrial cancer, yet limited randomized data examine the optimal dose/fractionation. We aimed to study short-course VCB ...